Frontlight ResearchEarly access
Trial site
Centro de Pesquisa Clinica do Coracao
- 9running trials
- 4closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Stroke4 trials
- Chronic kidney disease3 trials
- Coronary artery disease3 trials
- Heart failure3 trials
- Obesity3 trials
- High blood pressure2 trials
- Peripheral artery disease2 trials
- Type 2 diabetes2 trials
- Atrial fibrillation1 trial
- IgA nephropathy1 trial
- Phase
- Phase 310 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Active, not recruiting4 trials
- Completed4 trials
- Recruiting4 trials
- Not yet recruiting1 trial
- Lead sponsor
- Eli Lilly and Company5 trials
- Hospital Israelita Albert Einstein3 trials
- Boehringer Ingelheim2 trials
- Alpine Immune Sciences Inc, A Subsidiary of Vertex1 trial
- Amgen1 trial
- and 1 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Recruiting
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Active, not recruiting
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Stroke2 recruiting
- Atrial fibrillation1 recruiting
- Chronic kidney disease1 recruiting
- Heart failure1 recruiting
- Obesity1 recruiting
- Peripheral artery disease1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026